scholarly article | Q13442814 |
P2093 | author name string | Xiang Hu | |
Bin Shen | |||
Hua Wu | |||
Kai Cheng | |||
Zhen Cheng | |||
Frederick T Chin | |||
Jianghong Rao | |||
Xinhui Su | |||
Gianina Teribele Venturin | |||
Jongho Jeon | |||
P2860 | cites work | Radiolabeled peptides: valuable tools for the detection and treatment of cancer | Q39596344 |
Small-animal PET imaging of human epidermal growth factor receptor positive tumor with a 64Cu labeled affibody protein | Q39713379 | ||
Blocking EGFR in the liver improves the tumor-to-liver uptake ratio of radiolabeled EGF. | Q39720186 | ||
Efficient method for site-specific 18F-labeling of biomolecules using the rapid condensation reaction between 2-cyanobenzothiazole and cysteine | Q42044376 | ||
A novel method of 18F radiolabeling for PET. | Q46011404 | ||
Reducing renal uptake of radiolabeled peptides using albumin fragments | Q46429169 | ||
Gelatin-based plasma expander effectively reduces renal uptake of 111In-octreotide in mice and rats. | Q46972975 | ||
Engineered two-helix small proteins for molecular recognition | Q47863941 | ||
The epidermal growth factor receptor mediates radioresistance. | Q52011134 | ||
Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111In- or 68Ga-labeled affibody molecules. | Q54673289 | ||
Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor. | Q33282523 | ||
A novel facile method of labeling octreotide with (18)F-fluorine | Q34012587 | ||
Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules | Q34134412 | ||
64Cu-labeled affibody molecules for imaging of HER2 expressing tumors | Q34140651 | ||
PET of EGFR expression with an 18F-labeled affibody molecule | Q34429075 | ||
One-step radiosynthesis of ¹⁸F-AlF-NOTA-RGD₂ for tumor angiogenesis PET imaging | Q34435482 | ||
A 2-helix small protein labeled with 68Ga for PET imaging of HER2 expression | Q34435496 | ||
Safe and effective inhibition of renal uptake of radiolabelled octreotide by a combination of lysine and arginine | Q34529828 | ||
Epidermal growth factor receptor targeting in cancer | Q36557269 | ||
First experience of 18F-alfatide in lung cancer patients using a new lyophilized kit for rapid radiofluorination | Q36931413 | ||
Experimental results and related clinical implications of PET detection of epidermal growth factor receptor (EGFr) in cancer | Q37289600 | ||
Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts | Q39398599 | ||
EGFR-mediated G1/S transition contributes to the multidrug resistance in breast cancer cells | Q39426098 | ||
Imaging of human epidermal growth factor receptor type 2 expression with 18F-labeled affibody molecule ZHER2:2395 in a mouse model for ovarian cancer | Q39427521 | ||
Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro | Q39531950 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3947-3956 | |
P577 | publication date | 2014-07-14 | |
P1433 | published in | Molecular Pharmaceutics | Q3011140 |
P1476 | title | Comparison of two site-specifically (18)F-labeled affibodies for PET imaging of EGFR positive tumors | |
P478 | volume | 11 |
Q49797952 | 18F-AlF Labeled Peptide and Protein Conjugates as Positron Emission Tomography (PET) Imaging Pharmaceuticals. |
Q89030232 | 18F-AlF-Labeled Biomolecule Conjugates as Imaging Pharmaceuticals |
Q38815325 | 64Cu-Labeled Gp2 Domain for PET Imaging of Epidermal Growth Factor Receptor |
Q92503500 | A Comprehensive Review of Non-Covalent Radiofluorination Approaches Using Aluminum [18F]fluoride: Will [18F]AlF Replace 68Ga for Metal Chelate Labeling? |
Q28072407 | A current perspective on applications of macrocyclic-peptide-based high-affinity ligands |
Q90307333 | Affibody Molecules as Targeting Vectors for PET Imaging |
Q64080497 | Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models |
Q97419477 | Affibody-Modified Gd@C-Dots with Efficient Renal Clearance for Enhanced MRI of EGFR Expression in Non-Small-Cell Lung Cancer |
Q47658974 | Antidepressant Effects of Ketamine Are Not Related to ¹⁸F-FDG Metabolism or Tyrosine Hydroxylase Immunoreactivity in the Ventral Tegmental Area of Wistar Rats |
Q47158578 | Cyclic versus Noncyclic Chelating Scaffold for 89Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression |
Q90167820 | Dysregulated integrin αVβ3 and CD47 signaling promotes joint inflammation, cartilage breakdown, and progression of osteoarthritis |
Q41092700 | Evaluation of 99mTc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC. |
Q92998033 | Evaluation of affibody charge modification identified by synthetic consensus design in molecular PET imaging of epidermal growth factor receptor |
Q37427038 | Feasibility of imaging of epidermal growth factor receptor expression with ZEGFR:2377 affibody molecule labeled with 99mTc using a peptide-based cysteine-containing chelator. |
Q90581932 | ImmunoPET: Concept, Design, and Applications |
Q36235732 | Improving external beam radiotherapy by combination with internal irradiation |
Q52983939 | Novel chemoselective (18)F-radiolabeling of thiol-containing biomolecules under mild aqueous conditions. |
Q36649532 | PET imaging of epidermal growth factor receptor expression in tumours using 89Zr-labelled ZEGFR:2377 affibody molecules. |
Q38889580 | PET imaging of insulin-like growth factor type 1 receptor expression with a 64Cu-labeled Affibody molecule |
Q33776692 | PET of HER2 Expression with a Novel 18FAl Labeled Affibody |
Q58723385 | Preclinical Evaluation of [Ga]Ga-DFO-ZEGFR:2377: A Promising Affibody-Based Probe for Noninvasive PET Imaging of EGFR Expression in Tumors |
Q90461305 | Recent Advances in Bioorthogonal Click Chemistry for Efficient Synthesis of Radiotracers and Radiopharmaceuticals |
Q88008738 | Receptor Occupancy Imaging Studies in Oncology Drug Development |
Q45999663 | Site-Specific Radiofluorination of Biomolecules with 8-[(18)F]-Fluorooctanoic Acid Catalyzed by Lipoic Acid Ligase. |
Q51353652 | Small-Protein-Stabilized Semiconductor Nanoprobe for Targeted Imaging of Cancer Cells. |
Q91341298 | The beginning of the end for conventional RECIST - novel therapies require novel imaging approaches |
Q33920975 | The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule. |